xml_file stringlengths 5 11 | reference_id stringlengths 1 7 | date_last_updated stringclasses 487
values | pubmed_id stringlengths 5 8 ⌀ | article_year int64 1.95k 2.03k ⌀ | article_title stringlengths 23 347 ⌀ | journal_title stringlengths 3 197 ⌀ | authors stringlengths 5 2.35k ⌀ | epitope_id stringlengths 1 7 ⌀ | epitope_name stringlengths 1 85 ⌀ | epitope_structure_type stringclasses 8
values | epitope_chemical_type stringclasses 18
values | linear_sequence stringlengths 1 829 ⌀ | linear_sequence_length int64 1 829 ⌀ | discontinuous_residues stringlengths 2 419 ⌀ | starting_position int64 0 34.8k ⌀ | ending_position int64 3 34.8k ⌀ | source_organism_id stringlengths 1 8 ⌀ | source_molecule_genbank_id stringlengths 4 14 ⌀ | reference_region stringlengths 2 409 ⌀ | epitope_structure_defines stringclasses 4
values | epitope_evidence_code stringclasses 6
values | assay_category stringclasses 4
values | assay_id stringlengths 2 8 | assay_type_id stringclasses 412
values | assay_location_of_data stringlengths 4 126 ⌀ | qualitative_measurement stringclasses 5
values | is_positive bool 2
classes | quantitative_measurement stringlengths 3 25 ⌀ | host_organism_id stringclasses 729
values | host_sex stringclasses 2
values | host_age stringlengths 1 39 ⌀ | disease_state stringclasses 666
values | mhc_allele_id stringclasses 868
values | mhc_allele_types_present stringlengths 1 150 ⌀ | cell_type stringclasses 41
values | cell_tissue_type stringclasses 49
values | cell_culture_conditions stringclasses 9
values | antigen_evidence_code stringclasses 6
values | immunogen_evidence_code stringclasses 6
values | assay_comments stringclasses 0
values | split_bucket int64 1 9 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1000157.xml | 1000157 | 2025-11-06-08:00 | 16140434 | 2,006 | Uneven distribution of MHC class II epitopes within the influenza virus. | Vaccine | Sherry R Crowe; Shannon C Miller; Deborah M Brown; Pamela S Adams; Richard W Dutton; Allen G Harmsen; Frances E Lund; Troy D Randall; Susan L Swain; David L Woodland | 37728 | NS1 146-160 (x31) | FragmentOfANaturalSequenceMolecule | Peptide from protein | LLRAFTEEGAIVGEI | 15 | null | 146 | 160 | 132504 | Q76MT8.1 | null | Epitope containing region/antigenic site | Not determined | TCell | 1036029 | 48 | Figure 1 | Negative | false | null | 10000067 | F | 6-12 weeks | null | null | 167 168 | lymphocyte | spleen | Direct Ex Vivo | Exact match to reference information | Not determined | null | 7 |
1000157.xml | 1000157 | 2025-11-06-08:00 | 16140434 | 2,006 | Uneven distribution of MHC class II epitopes within the influenza virus. | Vaccine | Sherry R Crowe; Shannon C Miller; Deborah M Brown; Pamela S Adams; Richard W Dutton; Allen G Harmsen; Frances E Lund; Troy D Randall; Susan L Swain; David L Woodland | 63341 | NS1 151-165 (x31) | FragmentOfANaturalSequenceMolecule | Peptide from protein | TEEGAIVGEISPLPS | 15 | null | 151 | 165 | 132504 | Q76MT8.1 | null | Epitope containing region/antigenic site | Not determined | TCell | 1036030 | 48 | Figure 1 | Negative | false | null | 10000067 | F | 6-12 weeks | null | null | 167 168 | lymphocyte | spleen | Direct Ex Vivo | Exact match to reference information | Not determined | null | 1 |
1000157.xml | 1000157 | 2025-11-06-08:00 | 16140434 | 2,006 | Uneven distribution of MHC class II epitopes within the influenza virus. | Vaccine | Sherry R Crowe; Shannon C Miller; Deborah M Brown; Pamela S Adams; Richard W Dutton; Allen G Harmsen; Frances E Lund; Troy D Randall; Susan L Swain; David L Woodland | 29281 | NS1 156-170 (x31) | FragmentOfANaturalSequenceMolecule | Peptide from protein | IVGEISPLPSLPGHT | 15 | null | 156 | 170 | 132504 | Q76MT8.1 | null | Epitope containing region/antigenic site | Not determined | TCell | 1036031 | 48 | Figure 1 | Negative | false | null | 10000067 | F | 6-12 weeks | null | null | 167 168 | lymphocyte | spleen | Direct Ex Vivo | Exact match to reference information | Not determined | null | 3 |
1000157.xml | 1000157 | 2025-11-06-08:00 | 16140434 | 2,006 | Uneven distribution of MHC class II epitopes within the influenza virus. | Vaccine | Sherry R Crowe; Shannon C Miller; Deborah M Brown; Pamela S Adams; Richard W Dutton; Allen G Harmsen; Frances E Lund; Troy D Randall; Susan L Swain; David L Woodland | 60128 | NS1 161-175 (x31) | FragmentOfANaturalSequenceMolecule | Peptide from protein | SPLPSLPGHTAEDVK | 15 | null | 161 | 175 | 132504 | Q76MT8.1 | null | Epitope containing region/antigenic site | Not determined | TCell | 1036032 | 48 | Figure 1 | Negative | false | null | 10000067 | F | 6-12 weeks | null | null | 167 168 | lymphocyte | spleen | Direct Ex Vivo | Exact match to reference information | Not determined | null | 9 |
1000157.xml | 1000157 | 2025-11-06-08:00 | 16140434 | 2,006 | Uneven distribution of MHC class II epitopes within the influenza virus. | Vaccine | Sherry R Crowe; Shannon C Miller; Deborah M Brown; Pamela S Adams; Richard W Dutton; Allen G Harmsen; Frances E Lund; Troy D Randall; Susan L Swain; David L Woodland | 867 | NS1 171-185 (x31) | FragmentOfANaturalSequenceMolecule | Peptide from protein | AEDVKNAVGVLIGGL | 15 | null | 171 | 185 | 132504 | Q76MT8.1 | null | Epitope containing region/antigenic site | Not determined | TCell | 1036034 | 48 | Figure 1 | Negative | false | null | 10000067 | F | 6-12 weeks | null | null | 167 168 | lymphocyte | spleen | Direct Ex Vivo | Exact match to reference information | Not determined | null | 1 |
1000157.xml | 1000157 | 2025-11-06-08:00 | 16140434 | 2,006 | Uneven distribution of MHC class II epitopes within the influenza virus. | Vaccine | Sherry R Crowe; Shannon C Miller; Deborah M Brown; Pamela S Adams; Richard W Dutton; Allen G Harmsen; Frances E Lund; Troy D Randall; Susan L Swain; David L Woodland | 43333 | NS1 176-190 (x31) | FragmentOfANaturalSequenceMolecule | Peptide from protein | NAVGVLIGGLEWNDN | 15 | null | 176 | 190 | 132504 | Q76MT8.1 | null | Epitope containing region/antigenic site | Not determined | TCell | 1036035 | 48 | Figure 1 | Negative | false | null | 10000067 | F | 6-12 weeks | null | null | 167 168 | lymphocyte | spleen | Direct Ex Vivo | Exact match to reference information | Not determined | null | 3 |
1000157.xml | 1000157 | 2025-11-06-08:00 | 16140434 | 2,006 | Uneven distribution of MHC class II epitopes within the influenza virus. | Vaccine | Sherry R Crowe; Shannon C Miller; Deborah M Brown; Pamela S Adams; Richard W Dutton; Allen G Harmsen; Frances E Lund; Troy D Randall; Susan L Swain; David L Woodland | 36534 | NS1 181-195 (x31) | FragmentOfANaturalSequenceMolecule | Peptide from protein | LIGGLEWNDNTVRVS | 15 | null | 181 | 195 | 132504 | Q76MT8.1 | null | Epitope containing region/antigenic site | Not determined | TCell | 1036036 | 48 | Figure 1 | Negative | false | null | 10000067 | F | 6-12 weeks | null | null | 167 168 | lymphocyte | spleen | Direct Ex Vivo | Exact match to reference information | Not determined | null | 5 |
1000157.xml | 1000157 | 2025-11-06-08:00 | 16140434 | 2,006 | Uneven distribution of MHC class II epitopes within the influenza virus. | Vaccine | Sherry R Crowe; Shannon C Miller; Deborah M Brown; Pamela S Adams; Richard W Dutton; Allen G Harmsen; Frances E Lund; Troy D Randall; Susan L Swain; David L Woodland | 14946 | NS1 186-200 (x31) | FragmentOfANaturalSequenceMolecule | Peptide from protein | EWNDNTVRVSETLQR | 15 | null | 186 | 200 | 132504 | Q76MT8.1 | null | Epitope containing region/antigenic site | Not determined | TCell | 1036037 | 48 | Figure 1 | Negative | false | null | 10000067 | F | 6-12 weeks | null | null | 167 168 | lymphocyte | spleen | Direct Ex Vivo | Exact match to reference information | Not determined | null | 2 |
1000157.xml | 1000157 | 2025-11-06-08:00 | 16140434 | 2,006 | Uneven distribution of MHC class II epitopes within the influenza virus. | Vaccine | Sherry R Crowe; Shannon C Miller; Deborah M Brown; Pamela S Adams; Richard W Dutton; Allen G Harmsen; Frances E Lund; Troy D Randall; Susan L Swain; David L Woodland | 67136 | NS1 191-205 (x31) | FragmentOfANaturalSequenceMolecule | Peptide from protein | TVRVSETLQRFAWRS | 15 | null | 191 | 205 | 132504 | Q76MT8.1 | null | Epitope containing region/antigenic site | Not determined | TCell | 1036038 | 48 | Figure 1 | Negative | false | null | 10000067 | F | 6-12 weeks | null | null | 167 168 | lymphocyte | spleen | Direct Ex Vivo | Exact match to reference information | Not determined | null | 1 |
1000157.xml | 1000157 | 2025-11-06-08:00 | 16140434 | 2,006 | Uneven distribution of MHC class II epitopes within the influenza virus. | Vaccine | Sherry R Crowe; Shannon C Miller; Deborah M Brown; Pamela S Adams; Richard W Dutton; Allen G Harmsen; Frances E Lund; Troy D Randall; Susan L Swain; David L Woodland | 14470 | NS1 196-210 (x31) | FragmentOfANaturalSequenceMolecule | Peptide from protein | ETLQRFAWRSSNENG | 15 | null | 196 | 210 | 132504 | Q76MT8.1 | null | Epitope containing region/antigenic site | Not determined | TCell | 1036039 | 48 | Figure 1 | Negative | false | null | 10000067 | F | 6-12 weeks | null | null | 167 168 | lymphocyte | spleen | Direct Ex Vivo | Exact match to reference information | Not determined | null | 9 |
1000157.xml | 1000157 | 2025-11-06-08:00 | 16140434 | 2,006 | Uneven distribution of MHC class II epitopes within the influenza virus. | Vaccine | Sherry R Crowe; Shannon C Miller; Deborah M Brown; Pamela S Adams; Richard W Dutton; Allen G Harmsen; Frances E Lund; Troy D Randall; Susan L Swain; David L Woodland | 15304 | NS1 201-215 (x31) | FragmentOfANaturalSequenceMolecule | Peptide from protein | FAWRSSNENGRPPLT | 15 | null | 201 | 215 | 132504 | Q76MT8.1 | null | Epitope containing region/antigenic site | Not determined | TCell | 1036040 | 48 | Figure 1 | Negative | false | null | 10000067 | F | 6-12 weeks | null | null | 167 168 | lymphocyte | spleen | Direct Ex Vivo | Exact match to reference information | Not determined | null | 2 |
1000157.xml | 1000157 | 2025-11-06-08:00 | 16140434 | 2,006 | Uneven distribution of MHC class II epitopes within the influenza virus. | Vaccine | Sherry R Crowe; Shannon C Miller; Deborah M Brown; Pamela S Adams; Richard W Dutton; Allen G Harmsen; Frances E Lund; Troy D Randall; Susan L Swain; David L Woodland | 59819 | NS1 206-220 (x31) | FragmentOfANaturalSequenceMolecule | Peptide from protein | SNENGRPPLTPKQKR | 15 | null | 206 | 220 | 132504 | Q76MT8.1 | null | Epitope containing region/antigenic site | Not determined | TCell | 1036041 | 48 | Figure 1 | Negative | false | null | 10000067 | F | 6-12 weeks | null | null | 167 168 | lymphocyte | spleen | Direct Ex Vivo | Exact match to reference information | Not determined | null | 9 |
1000157.xml | 1000157 | 2025-11-06-08:00 | 16140434 | 2,006 | Uneven distribution of MHC class II epitopes within the influenza virus. | Vaccine | Sherry R Crowe; Shannon C Miller; Deborah M Brown; Pamela S Adams; Richard W Dutton; Allen G Harmsen; Frances E Lund; Troy D Randall; Susan L Swain; David L Woodland | 55259 | NS1 211-225 (x31) | FragmentOfANaturalSequenceMolecule | Peptide from protein | RPPLTPKQKREMAGT | 15 | null | 211 | 225 | 132504 | Q76MT8.1 | null | Epitope containing region/antigenic site | Not determined | TCell | 1036042 | 48 | Figure 1 | Negative | false | null | 10000067 | F | 6-12 weeks | null | null | 167 168 | lymphocyte | spleen | Direct Ex Vivo | Exact match to reference information | Not determined | null | 4 |
1000157.xml | 1000157 | 2025-11-06-08:00 | 16140434 | 2,006 | Uneven distribution of MHC class II epitopes within the influenza virus. | Vaccine | Sherry R Crowe; Shannon C Miller; Deborah M Brown; Pamela S Adams; Richard W Dutton; Allen G Harmsen; Frances E Lund; Troy D Randall; Susan L Swain; David L Woodland | 48130 | NS1 216-230 (x31) | FragmentOfANaturalSequenceMolecule | Peptide from protein | PKQKREMAGTIRSEV | 15 | null | 216 | 230 | 132504 | Q76MT8.1 | null | Epitope containing region/antigenic site | Not determined | TCell | 1036043 | 48 | Figure 1 | Negative | false | null | 10000067 | F | 6-12 weeks | null | null | 167 168 | lymphocyte | spleen | Direct Ex Vivo | Exact match to reference information | Not determined | null | 5 |
1000157.xml | 1000157 | 2025-11-06-08:00 | 16140434 | 2,006 | Uneven distribution of MHC class II epitopes within the influenza virus. | Vaccine | Sherry R Crowe; Shannon C Miller; Deborah M Brown; Pamela S Adams; Richard W Dutton; Allen G Harmsen; Frances E Lund; Troy D Randall; Susan L Swain; David L Woodland | 13347 | NS1 221-230 (x31) | FragmentOfANaturalSequenceMolecule | Peptide from protein | EMAGTIRSEV | 10 | null | 221 | 230 | 132504 | Q76MT8.1 | null | Exact Epitope | Not determined | TCell | 1036044 | 48 | Figure 1 | Negative | false | null | 10000067 | F | 6-12 weeks | null | null | 167 168 | lymphocyte | spleen | Direct Ex Vivo | Exact match to reference information | Not determined | null | 1 |
1000157.xml | 1000157 | 2025-11-06-08:00 | 16140434 | 2,006 | Uneven distribution of MHC class II epitopes within the influenza virus. | Vaccine | Sherry R Crowe; Shannon C Miller; Deborah M Brown; Pamela S Adams; Richard W Dutton; Allen G Harmsen; Frances E Lund; Troy D Randall; Susan L Swain; David L Woodland | 42556 | M1 1-15 (x31) | FragmentOfANaturalSequenceMolecule | Peptide from protein | MSFLTEVETYVLSII | 15 | null | 1 | 15 | 132504 | Q9IQ48.1 | null | Epitope containing region/antigenic site | Not determined | TCell | 1036045 | 48 | Figure 1 | Negative | false | null | 10000067 | F | 6-12 weeks | null | null | 167 168 | lymphocyte | spleen | Direct Ex Vivo | Exact match to reference information | Not determined | null | 1 |
1000157.xml | 1000157 | 2025-11-06-08:00 | 16140434 | 2,006 | Uneven distribution of MHC class II epitopes within the influenza virus. | Vaccine | Sherry R Crowe; Shannon C Miller; Deborah M Brown; Pamela S Adams; Richard W Dutton; Allen G Harmsen; Frances E Lund; Troy D Randall; Susan L Swain; David L Woodland | 14688 | M1 6-20 (x31) | FragmentOfANaturalSequenceMolecule | Peptide from protein | EVETYVLSIIPSGPL | 15 | null | 6 | 20 | 132504 | Q9IQ48.1 | null | Epitope containing region/antigenic site | Not determined | TCell | 1036046 | 48 | Figure 1 | Negative | false | null | 10000067 | F | 6-12 weeks | null | null | 167 168 | lymphocyte | spleen | Direct Ex Vivo | Exact match to reference information | Not determined | null | 9 |
1000157.xml | 1000157 | 2025-11-06-08:00 | 16140434 | 2,006 | Uneven distribution of MHC class II epitopes within the influenza virus. | Vaccine | Sherry R Crowe; Shannon C Miller; Deborah M Brown; Pamela S Adams; Richard W Dutton; Allen G Harmsen; Frances E Lund; Troy D Randall; Susan L Swain; David L Woodland | 69773 | M1 11-25 (x31) | FragmentOfANaturalSequenceMolecule | Peptide from protein | VLSIIPSGPLKAEIA | 15 | null | 11 | 25 | 132504 | Q9IQ48.1 | null | Epitope containing region/antigenic site | Not determined | TCell | 1036047 | 48 | Figure 1 | Negative | false | null | 10000067 | F | 6-12 weeks | null | null | 167 168 | lymphocyte | spleen | Direct Ex Vivo | Exact match to reference information | Not determined | null | 6 |
1000157.xml | 1000157 | 2025-11-06-08:00 | 16140434 | 2,006 | Uneven distribution of MHC class II epitopes within the influenza virus. | Vaccine | Sherry R Crowe; Shannon C Miller; Deborah M Brown; Pamela S Adams; Richard W Dutton; Allen G Harmsen; Frances E Lund; Troy D Randall; Susan L Swain; David L Woodland | 49384 | M1 16-30 (x31) | FragmentOfANaturalSequenceMolecule | Peptide from protein | PSGPLKAEIAQRLED | 15 | null | 16 | 30 | 132504 | Q9IQ48.1 | null | Epitope containing region/antigenic site | Not determined | TCell | 1036048 | 48 | Figure 1 | Negative | false | null | 10000067 | F | 6-12 weeks | null | null | 167 168 | lymphocyte | spleen | Direct Ex Vivo | Exact match to reference information | Not determined | null | 3 |
1000157.xml | 1000157 | 2025-11-06-08:00 | 16140434 | 2,006 | Uneven distribution of MHC class II epitopes within the influenza virus. | Vaccine | Sherry R Crowe; Shannon C Miller; Deborah M Brown; Pamela S Adams; Richard W Dutton; Allen G Harmsen; Frances E Lund; Troy D Randall; Susan L Swain; David L Woodland | 68424 | M1 31-45 (x31) | FragmentOfANaturalSequenceMolecule | Peptide from protein | VFAGKNTDLEVLMEW | 15 | null | 31 | 45 | 132504 | Q9IQ48.1 | null | Epitope containing region/antigenic site | Not determined | TCell | 1036051 | 48 | Figure 1 | Negative | false | null | 10000067 | F | 6-12 weeks | null | null | 167 168 | lymphocyte | spleen | Direct Ex Vivo | Exact match to reference information | Not determined | null | 7 |
1000157.xml | 1000157 | 2025-11-06-08:00 | 16140434 | 2,006 | Uneven distribution of MHC class II epitopes within the influenza virus. | Vaccine | Sherry R Crowe; Shannon C Miller; Deborah M Brown; Pamela S Adams; Richard W Dutton; Allen G Harmsen; Frances E Lund; Troy D Randall; Susan L Swain; David L Woodland | 46076 | M1 36-50 (x31) | FragmentOfANaturalSequenceMolecule | Peptide from protein | NTDLEVLMEWLKTRP | 15 | null | 36 | 50 | 132504 | Q9IQ48.1 | null | Epitope containing region/antigenic site | Not determined | TCell | 1036052 | 48 | Figure 1 | Negative | false | null | 10000067 | F | 6-12 weeks | null | null | 167 168 | lymphocyte | spleen | Direct Ex Vivo | Exact match to reference information | Not determined | null | 8 |
1000157.xml | 1000157 | 2025-11-06-08:00 | 16140434 | 2,006 | Uneven distribution of MHC class II epitopes within the influenza virus. | Vaccine | Sherry R Crowe; Shannon C Miller; Deborah M Brown; Pamela S Adams; Richard W Dutton; Allen G Harmsen; Frances E Lund; Troy D Randall; Susan L Swain; David L Woodland | 69641 | M1 41-55 (x31) | FragmentOfANaturalSequenceMolecule | Peptide from protein | VLMEWLKTRPILSPL | 15 | null | 41 | 55 | 132504 | Q9IQ48.1 | null | Epitope containing region/antigenic site | Not determined | TCell | 1036053 | 48 | Figure 1 | Negative | false | null | 10000067 | F | 6-12 weeks | null | null | 167 168 | lymphocyte | spleen | Direct Ex Vivo | Exact match to reference information | Not determined | null | 4 |
1000157.xml | 1000157 | 2025-11-06-08:00 | 16140434 | 2,006 | Uneven distribution of MHC class II epitopes within the influenza virus. | Vaccine | Sherry R Crowe; Shannon C Miller; Deborah M Brown; Pamela S Adams; Richard W Dutton; Allen G Harmsen; Frances E Lund; Troy D Randall; Susan L Swain; David L Woodland | 37042 | M1 46-60 (x31) | FragmentOfANaturalSequenceMolecule | Peptide from protein | LKTRPILSPLTKGIL | 15 | null | 46 | 60 | 132504 | Q9IQ48.1 | null | Epitope containing region/antigenic site | Not determined | TCell | 1036054 | 48 | Figure 1 | Negative | false | null | 10000067 | F | 6-12 weeks | null | null | 167 168 | lymphocyte | spleen | Direct Ex Vivo | Exact match to reference information | Not determined | null | 5 |
1000157.xml | 1000157 | 2025-11-06-08:00 | 16140434 | 2,006 | Uneven distribution of MHC class II epitopes within the influenza virus. | Vaccine | Sherry R Crowe; Shannon C Miller; Deborah M Brown; Pamela S Adams; Richard W Dutton; Allen G Harmsen; Frances E Lund; Troy D Randall; Susan L Swain; David L Woodland | 27351 | M1 51-65 (x31) | FragmentOfANaturalSequenceMolecule | Peptide from protein | ILSPLTKGILGFVFT | 15 | null | 51 | 65 | 132504 | Q9IQ48.1 | null | Epitope containing region/antigenic site | Not determined | TCell | 1036055 | 48 | Figure 1 | Negative | false | null | 10000067 | F | 6-12 weeks | null | null | 167 168 | lymphocyte | spleen | Direct Ex Vivo | Exact match to reference information | Not determined | null | 6 |
1000157.xml | 1000157 | 2025-11-06-08:00 | 16140434 | 2,006 | Uneven distribution of MHC class II epitopes within the influenza virus. | Vaccine | Sherry R Crowe; Shannon C Miller; Deborah M Brown; Pamela S Adams; Richard W Dutton; Allen G Harmsen; Frances E Lund; Troy D Randall; Susan L Swain; David L Woodland | 64577 | M1 56-70 (x31) | FragmentOfANaturalSequenceMolecule | Peptide from protein | TKGILGFVFTLTVPS | 15 | null | 56 | 70 | 132504 | Q9IQ48.1 | null | Epitope containing region/antigenic site | Not determined | TCell | 1036056 | 48 | Figure 1 | Negative | false | null | 10000067 | F | 6-12 weeks | null | null | 167 168 | lymphocyte | spleen | Direct Ex Vivo | Exact match to reference information | Not determined | null | 4 |
1000157.xml | 1000157 | 2025-11-06-08:00 | 16140434 | 2,006 | Uneven distribution of MHC class II epitopes within the influenza virus. | Vaccine | Sherry R Crowe; Shannon C Miller; Deborah M Brown; Pamela S Adams; Richard W Dutton; Allen G Harmsen; Frances E Lund; Troy D Randall; Susan L Swain; David L Woodland | 19642 | M1 61-75 (x31) | FragmentOfANaturalSequenceMolecule | Peptide from protein | GFVFTLTVPSERGLQ | 15 | null | 61 | 75 | 132504 | Q9IQ48.1 | null | Epitope containing region/antigenic site | Not determined | TCell | 1036057 | 48 | Figure 1 | Negative | false | null | 10000067 | F | 6-12 weeks | null | null | 167 168 | lymphocyte | spleen | Direct Ex Vivo | Exact match to reference information | Not determined | null | 6 |
1000157.xml | 1000157 | 2025-11-06-08:00 | 16140434 | 2,006 | Uneven distribution of MHC class II epitopes within the influenza virus. | Vaccine | Sherry R Crowe; Shannon C Miller; Deborah M Brown; Pamela S Adams; Richard W Dutton; Allen G Harmsen; Frances E Lund; Troy D Randall; Susan L Swain; David L Woodland | 40226 | M1 66-80 (x31) | FragmentOfANaturalSequenceMolecule | Peptide from protein | LTVPSERGLQRRRFV | 15 | null | 66 | 80 | 132504 | Q9IQ48.1 | null | Epitope containing region/antigenic site | Not determined | TCell | 1036058 | 48 | Figure 1 | Negative | false | null | 10000067 | F | 6-12 weeks | null | null | 167 168 | lymphocyte | spleen | Direct Ex Vivo | Exact match to reference information | Not determined | null | 7 |
1000157.xml | 1000157 | 2025-11-06-08:00 | 16140434 | 2,006 | Uneven distribution of MHC class II epitopes within the influenza virus. | Vaccine | Sherry R Crowe; Shannon C Miller; Deborah M Brown; Pamela S Adams; Richard W Dutton; Allen G Harmsen; Frances E Lund; Troy D Randall; Susan L Swain; David L Woodland | 13998 | M1 71-85 (x31) | FragmentOfANaturalSequenceMolecule | Peptide from protein | ERGLQRRRFVQNALN | 15 | null | 71 | 85 | 132504 | Q9IQ48.1 | null | Epitope containing region/antigenic site | Not determined | TCell | 1036059 | 48 | Figure 1 | Negative | false | null | 10000067 | F | 6-12 weeks | null | null | 167 168 | lymphocyte | spleen | Direct Ex Vivo | Exact match to reference information | Not determined | null | 9 |
1000157.xml | 1000157 | 2025-11-06-08:00 | 16140434 | 2,006 | Uneven distribution of MHC class II epitopes within the influenza virus. | Vaccine | Sherry R Crowe; Shannon C Miller; Deborah M Brown; Pamela S Adams; Richard W Dutton; Allen G Harmsen; Frances E Lund; Troy D Randall; Susan L Swain; David L Woodland | 55708 | M1 76-90 (x31) | FragmentOfANaturalSequenceMolecule | Peptide from protein | RRRFVQNALNGNGDP | 15 | null | 76 | 90 | 132504 | Q9IQ48.1 | null | Epitope containing region/antigenic site | Not determined | TCell | 1036060 | 48 | Figure 1 | Negative | false | null | 10000067 | F | 6-12 weeks | null | null | 167 168 | lymphocyte | spleen | Direct Ex Vivo | Exact match to reference information | Not determined | null | 8 |
1000157.xml | 1000157 | 2025-11-06-08:00 | 16140434 | 2,006 | Uneven distribution of MHC class II epitopes within the influenza virus. | Vaccine | Sherry R Crowe; Shannon C Miller; Deborah M Brown; Pamela S Adams; Richard W Dutton; Allen G Harmsen; Frances E Lund; Troy D Randall; Susan L Swain; David L Woodland | 51667 | M1 81-95 (x31) | FragmentOfANaturalSequenceMolecule | Peptide from protein | QNALNGNGDPNNMDK | 15 | null | 81 | 95 | 132504 | Q9IQ48.1 | null | Epitope containing region/antigenic site | Not determined | TCell | 1036061 | 48 | Figure 1 | Negative | false | null | 10000067 | F | 6-12 weeks | null | null | 167 168 | lymphocyte | spleen | Direct Ex Vivo | Exact match to reference information | Not determined | null | 2 |
1000157.xml | 1000157 | 2025-11-06-08:00 | 16140434 | 2,006 | Uneven distribution of MHC class II epitopes within the influenza virus. | Vaccine | Sherry R Crowe; Shannon C Miller; Deborah M Brown; Pamela S Adams; Richard W Dutton; Allen G Harmsen; Frances E Lund; Troy D Randall; Susan L Swain; David L Woodland | 21432 | M1 86-100 (x31) | FragmentOfANaturalSequenceMolecule | Peptide from protein | GNGDPNNMDKAVKLY | 15 | null | 86 | 100 | 132504 | Q9IQ48.1 | null | Epitope containing region/antigenic site | Not determined | TCell | 1036062 | 48 | Figure 1 | Negative | false | null | 10000067 | F | 6-12 weeks | null | null | 167 168 | lymphocyte | spleen | Direct Ex Vivo | Exact match to reference information | Not determined | null | 4 |
1000157.xml | 1000157 | 2025-11-06-08:00 | 16140434 | 2,006 | Uneven distribution of MHC class II epitopes within the influenza virus. | Vaccine | Sherry R Crowe; Shannon C Miller; Deborah M Brown; Pamela S Adams; Richard W Dutton; Allen G Harmsen; Frances E Lund; Troy D Randall; Susan L Swain; David L Woodland | 45176 | M1 91-105 (x31) | FragmentOfANaturalSequenceMolecule | Peptide from protein | NNMDKAVKLYRKLKR | 15 | null | 91 | 105 | 132504 | Q9IQ48.1 | null | Epitope containing region/antigenic site | Not determined | TCell | 1036063 | 48 | Figure 1 | Negative | false | null | 10000067 | F | 6-12 weeks | null | null | 167 168 | lymphocyte | spleen | Direct Ex Vivo | Exact match to reference information | Not determined | null | 1 |
1000157.xml | 1000157 | 2025-11-06-08:00 | 16140434 | 2,006 | Uneven distribution of MHC class II epitopes within the influenza virus. | Vaccine | Sherry R Crowe; Shannon C Miller; Deborah M Brown; Pamela S Adams; Richard W Dutton; Allen G Harmsen; Frances E Lund; Troy D Randall; Susan L Swain; David L Woodland | 54386 | M1 101-115 (x31) | FragmentOfANaturalSequenceMolecule | Peptide from protein | RKLKREITFHGAKEI | 15 | null | 101 | 115 | 132504 | Q9IQ48.1 | null | Epitope containing region/antigenic site | Not determined | TCell | 1036065 | 48 | Figure 1 | Negative | false | null | 10000067 | F | 6-12 weeks | null | null | 167 168 | lymphocyte | spleen | Direct Ex Vivo | Exact match to reference information | Not determined | null | 1 |
1000157.xml | 1000157 | 2025-11-06-08:00 | 16140434 | 2,006 | Uneven distribution of MHC class II epitopes within the influenza virus. | Vaccine | Sherry R Crowe; Shannon C Miller; Deborah M Brown; Pamela S Adams; Richard W Dutton; Allen G Harmsen; Frances E Lund; Troy D Randall; Susan L Swain; David L Woodland | 12590 | M1 106-120 (x31) | FragmentOfANaturalSequenceMolecule | Peptide from protein | EITFHGAKEISLSYS | 15 | null | 106 | 120 | 132504 | Q9IQ48.1 | null | Epitope containing region/antigenic site | Not determined | TCell | 1036066 | 48 | Figure 1 | Negative | false | null | 10000067 | F | 6-12 weeks | null | null | 167 168 | lymphocyte | spleen | Direct Ex Vivo | Exact match to reference information | Not determined | null | 8 |
1000157.xml | 1000157 | 2025-11-06-08:00 | 16140434 | 2,006 | Uneven distribution of MHC class II epitopes within the influenza virus. | Vaccine | Sherry R Crowe; Shannon C Miller; Deborah M Brown; Pamela S Adams; Richard W Dutton; Allen G Harmsen; Frances E Lund; Troy D Randall; Susan L Swain; David L Woodland | 18637 | M1 111-125 (x31) | FragmentOfANaturalSequenceMolecule | Peptide from protein | GAKEISLSYSAGALA | 15 | null | 111 | 125 | 132504 | Q9IQ48.1 | null | Epitope containing region/antigenic site | Not determined | TCell | 1036067 | 48 | Figure 1 | Negative | false | null | 10000067 | F | 6-12 weeks | null | null | 167 168 | lymphocyte | spleen | Direct Ex Vivo | Exact match to reference information | Not determined | null | 4 |
1000157.xml | 1000157 | 2025-11-06-08:00 | 16140434 | 2,006 | Uneven distribution of MHC class II epitopes within the influenza virus. | Vaccine | Sherry R Crowe; Shannon C Miller; Deborah M Brown; Pamela S Adams; Richard W Dutton; Allen G Harmsen; Frances E Lund; Troy D Randall; Susan L Swain; David L Woodland | 59494 | M1 116-130 (x31) | FragmentOfANaturalSequenceMolecule | Peptide from protein | SLSYSAGALASCMGL | 15 | null | 116 | 130 | 132504 | Q9IQ48.1 | null | Epitope containing region/antigenic site | Not determined | TCell | 1036068 | 48 | Figure 1 | Negative | false | null | 10000067 | F | 6-12 weeks | null | null | 167 168 | lymphocyte | spleen | Direct Ex Vivo | Exact match to reference information | Not determined | null | 1 |
1000157.xml | 1000157 | 2025-11-06-08:00 | 16140434 | 2,006 | Uneven distribution of MHC class II epitopes within the influenza virus. | Vaccine | Sherry R Crowe; Shannon C Miller; Deborah M Brown; Pamela S Adams; Richard W Dutton; Allen G Harmsen; Frances E Lund; Troy D Randall; Susan L Swain; David L Woodland | 1447 | M1 121-135 (x31) | FragmentOfANaturalSequenceMolecule | Peptide from protein | AGALASCMGLIYNRM | 15 | null | 121 | 135 | 132504 | Q9IQ48.1 | null | Epitope containing region/antigenic site | Not determined | TCell | 1036069 | 48 | Figure 1 | Negative | false | null | 10000067 | F | 6-12 weeks | null | null | 167 168 | lymphocyte | spleen | Direct Ex Vivo | Exact match to reference information | Not determined | null | 3 |
1000157.xml | 1000157 | 2025-11-06-08:00 | 16140434 | 2,006 | Uneven distribution of MHC class II epitopes within the influenza virus. | Vaccine | Sherry R Crowe; Shannon C Miller; Deborah M Brown; Pamela S Adams; Richard W Dutton; Allen G Harmsen; Frances E Lund; Troy D Randall; Susan L Swain; David L Woodland | 57117 | M1 126-140 (x31) | FragmentOfANaturalSequenceMolecule | Peptide from protein | SCMGLIYNRMGAVTT | 15 | null | 126 | 140 | 132504 | Q9IQ48.1 | null | Epitope containing region/antigenic site | Not determined | TCell | 1036070 | 48 | Figure 1 | Negative | false | null | 10000067 | F | 6-12 weeks | null | null | 167 168 | lymphocyte | spleen | Direct Ex Vivo | Exact match to reference information | Not determined | null | 6 |
1000157.xml | 1000157 | 2025-11-06-08:00 | 16140434 | 2,006 | Uneven distribution of MHC class II epitopes within the influenza virus. | Vaccine | Sherry R Crowe; Shannon C Miller; Deborah M Brown; Pamela S Adams; Richard W Dutton; Allen G Harmsen; Frances E Lund; Troy D Randall; Susan L Swain; David L Woodland | 29640 | M1 131-145 (x31) | FragmentOfANaturalSequenceMolecule | Peptide from protein | IYNRMGAVTTEVAFG | 15 | null | 131 | 145 | 132504 | Q9IQ48.1 | null | Epitope containing region/antigenic site | Not determined | TCell | 1036071 | 48 | Figure 1 | Negative | false | null | 10000067 | F | 6-12 weeks | null | null | 167 168 | lymphocyte | spleen | Direct Ex Vivo | Exact match to reference information | Not determined | null | 4 |
1000157.xml | 1000157 | 2025-11-06-08:00 | 16140434 | 2,006 | Uneven distribution of MHC class II epitopes within the influenza virus. | Vaccine | Sherry R Crowe; Shannon C Miller; Deborah M Brown; Pamela S Adams; Richard W Dutton; Allen G Harmsen; Frances E Lund; Troy D Randall; Susan L Swain; David L Woodland | 18831 | M1 136-150 (x31) | FragmentOfANaturalSequenceMolecule | Peptide from protein | GAVTTEVAFGLVCAT | 15 | null | 136 | 150 | 132504 | Q9IQ48.1 | null | Epitope containing region/antigenic site | Not determined | TCell | 1036072 | 48 | Figure 1 | Negative | false | null | 10000067 | F | 6-12 weeks | null | null | 167 168 | lymphocyte | spleen | Direct Ex Vivo | Exact match to reference information | Not determined | null | 6 |
1000157.xml | 1000157 | 2025-11-06-08:00 | 16140434 | 2,006 | Uneven distribution of MHC class II epitopes within the influenza virus. | Vaccine | Sherry R Crowe; Shannon C Miller; Deborah M Brown; Pamela S Adams; Richard W Dutton; Allen G Harmsen; Frances E Lund; Troy D Randall; Susan L Swain; David L Woodland | 14623 | M1 141-155 (x31) | FragmentOfANaturalSequenceMolecule | Peptide from protein | EVAFGLVCATCEQIA | 15 | null | 141 | 155 | 132504 | Q9IQ48.1 | null | Epitope containing region/antigenic site | Not determined | TCell | 1036073 | 48 | Figure 1 | Negative | false | null | 10000067 | F | 6-12 weeks | null | null | 167 168 | lymphocyte | spleen | Direct Ex Vivo | Exact match to reference information | Not determined | null | 2 |
1000157.xml | 1000157 | 2025-11-06-08:00 | 16140434 | 2,006 | Uneven distribution of MHC class II epitopes within the influenza virus. | Vaccine | Sherry R Crowe; Shannon C Miller; Deborah M Brown; Pamela S Adams; Richard W Dutton; Allen G Harmsen; Frances E Lund; Troy D Randall; Susan L Swain; David L Woodland | 40284 | M1 146-160 (x31) | FragmentOfANaturalSequenceMolecule | Peptide from protein | LVCATCEQIADSQHR | 15 | null | 146 | 160 | 132504 | Q9IQ48.1 | null | Epitope containing region/antigenic site | Not determined | TCell | 1036074 | 48 | Figure 1 | Negative | false | null | 10000067 | F | 6-12 weeks | null | null | 167 168 | lymphocyte | spleen | Direct Ex Vivo | Exact match to reference information | Not determined | null | 7 |
1000157.xml | 1000157 | 2025-11-06-08:00 | 16140434 | 2,006 | Uneven distribution of MHC class II epitopes within the influenza virus. | Vaccine | Sherry R Crowe; Shannon C Miller; Deborah M Brown; Pamela S Adams; Richard W Dutton; Allen G Harmsen; Frances E Lund; Troy D Randall; Susan L Swain; David L Woodland | 6189 | M1 151-165 (x31) | FragmentOfANaturalSequenceMolecule | Peptide from protein | CEQIADSQHRSHRQM | 15 | null | 151 | 165 | 132504 | Q9IQ48.1 | null | Epitope containing region/antigenic site | Not determined | TCell | 1036075 | 48 | Figure 1 | Negative | false | null | 10000067 | F | 6-12 weeks | null | null | 167 168 | lymphocyte | spleen | Direct Ex Vivo | Exact match to reference information | Not determined | null | 4 |
1000157.xml | 1000157 | 2025-11-06-08:00 | 16140434 | 2,006 | Uneven distribution of MHC class II epitopes within the influenza virus. | Vaccine | Sherry R Crowe; Shannon C Miller; Deborah M Brown; Pamela S Adams; Richard W Dutton; Allen G Harmsen; Frances E Lund; Troy D Randall; Susan L Swain; David L Woodland | 10213 | M1 156-170 (x31) | FragmentOfANaturalSequenceMolecule | Peptide from protein | DSQHRSHRQMVTTTN | 15 | null | 156 | 170 | 132504 | Q9IQ48.1 | null | Epitope containing region/antigenic site | Not determined | TCell | 1036076 | 48 | Figure 1 | Negative | false | null | 10000067 | F | 6-12 weeks | null | null | 167 168 | lymphocyte | spleen | Direct Ex Vivo | Exact match to reference information | Not determined | null | 4 |
1000157.xml | 1000157 | 2025-11-06-08:00 | 16140434 | 2,006 | Uneven distribution of MHC class II epitopes within the influenza virus. | Vaccine | Sherry R Crowe; Shannon C Miller; Deborah M Brown; Pamela S Adams; Richard W Dutton; Allen G Harmsen; Frances E Lund; Troy D Randall; Susan L Swain; David L Woodland | 71541 | M1 166-180 (x31) | FragmentOfANaturalSequenceMolecule | Peptide from protein | VTTTNPLIRHENRMV | 15 | null | 166 | 180 | 132504 | Q9IQ48.1 | null | Epitope containing region/antigenic site | Not determined | TCell | 1036078 | 48 | Figure 1 | Negative | false | null | 10000067 | F | 6-12 weeks | null | null | 167 168 | lymphocyte | spleen | Direct Ex Vivo | Exact match to reference information | Not determined | null | 3 |
1000157.xml | 1000157 | 2025-11-06-08:00 | 16140434 | 2,006 | Uneven distribution of MHC class II epitopes within the influenza virus. | Vaccine | Sherry R Crowe; Shannon C Miller; Deborah M Brown; Pamela S Adams; Richard W Dutton; Allen G Harmsen; Frances E Lund; Troy D Randall; Susan L Swain; David L Woodland | 48368 | M1 171-185 (x31) | FragmentOfANaturalSequenceMolecule | Peptide from protein | PLIRHENRMVLASTT | 15 | null | 171 | 185 | 132504 | Q9IQ48.1 | null | Epitope containing region/antigenic site | Not determined | TCell | 1036079 | 48 | Figure 1 | Negative | false | null | 10000067 | F | 6-12 weeks | null | null | 167 168 | lymphocyte | spleen | Direct Ex Vivo | Exact match to reference information | Not determined | null | 4 |
1000157.xml | 1000157 | 2025-11-06-08:00 | 16140434 | 2,006 | Uneven distribution of MHC class II epitopes within the influenza virus. | Vaccine | Sherry R Crowe; Shannon C Miller; Deborah M Brown; Pamela S Adams; Richard W Dutton; Allen G Harmsen; Frances E Lund; Troy D Randall; Susan L Swain; David L Woodland | 13582 | M1 176-190 (x31) | FragmentOfANaturalSequenceMolecule | Peptide from protein | ENRMVLASTTAKAME | 15 | null | 176 | 190 | 132504 | Q9IQ48.1 | null | Epitope containing region/antigenic site | Not determined | TCell | 1036080 | 48 | Figure 1 | Negative | false | null | 10000067 | F | 6-12 weeks | null | null | 167 168 | lymphocyte | spleen | Direct Ex Vivo | Exact match to reference information | Not determined | null | 8 |
1000157.xml | 1000157 | 2025-11-06-08:00 | 16140434 | 2,006 | Uneven distribution of MHC class II epitopes within the influenza virus. | Vaccine | Sherry R Crowe; Shannon C Miller; Deborah M Brown; Pamela S Adams; Richard W Dutton; Allen G Harmsen; Frances E Lund; Troy D Randall; Susan L Swain; David L Woodland | 34974 | M1 181-195 (x31) | FragmentOfANaturalSequenceMolecule | Peptide from protein | LASTTAKAMEQMAGS | 15 | null | 181 | 195 | 132504 | Q9IQ48.1 | null | Epitope containing region/antigenic site | Not determined | TCell | 1036081 | 48 | Figure 1 | Negative | false | null | 10000067 | F | 6-12 weeks | null | null | 167 168 | lymphocyte | spleen | Direct Ex Vivo | Exact match to reference information | Not determined | null | 8 |
1000157.xml | 1000157 | 2025-11-06-08:00 | 16140434 | 2,006 | Uneven distribution of MHC class II epitopes within the influenza virus. | Vaccine | Sherry R Crowe; Shannon C Miller; Deborah M Brown; Pamela S Adams; Richard W Dutton; Allen G Harmsen; Frances E Lund; Troy D Randall; Susan L Swain; David L Woodland | 2153 | M1 186-200 (x31) | FragmentOfANaturalSequenceMolecule | Peptide from protein | AKAMEQMAGSSEQAA | 15 | null | 186 | 200 | 132504 | Q9IQ48.1 | null | Epitope containing region/antigenic site | Not determined | TCell | 1036082 | 48 | Figure 1 | Negative | false | null | 10000067 | F | 6-12 weeks | null | null | 167 168 | lymphocyte | spleen | Direct Ex Vivo | Exact match to reference information | Not determined | null | 8 |
1000157.xml | 1000157 | 2025-11-06-08:00 | 16140434 | 2,006 | Uneven distribution of MHC class II epitopes within the influenza virus. | Vaccine | Sherry R Crowe; Shannon C Miller; Deborah M Brown; Pamela S Adams; Richard W Dutton; Allen G Harmsen; Frances E Lund; Troy D Randall; Susan L Swain; David L Woodland | 57595 | M1 196-210 (x31) | FragmentOfANaturalSequenceMolecule | Peptide from protein | SEQAAEAMEVASQAR | 15 | null | 196 | 210 | 132504 | Q9IQ48.1 | null | Epitope containing region/antigenic site | Not determined | TCell | 1036084 | 48 | Figure 1 | Negative | false | null | 10000067 | F | 6-12 weeks | null | null | 167 168 | lymphocyte | spleen | Direct Ex Vivo | Exact match to reference information | Not determined | null | 4 |
1000157.xml | 1000157 | 2025-11-06-08:00 | 16140434 | 2,006 | Uneven distribution of MHC class II epitopes within the influenza virus. | Vaccine | Sherry R Crowe; Shannon C Miller; Deborah M Brown; Pamela S Adams; Richard W Dutton; Allen G Harmsen; Frances E Lund; Troy D Randall; Susan L Swain; David L Woodland | 4688 | M1 206-220 (x31) | FragmentOfANaturalSequenceMolecule | Peptide from protein | ASQARQMVQAMITIG | 15 | null | 206 | 220 | 132504 | Q9IQ48.1 | null | Epitope containing region/antigenic site | Not determined | TCell | 1036085 | 48 | Figure 1 | Negative | false | null | 10000067 | F | 6-12 weeks | null | null | 167 168 | lymphocyte | spleen | Direct Ex Vivo | Exact match to reference information | Not determined | null | 2 |
1000157.xml | 1000157 | 2025-11-06-08:00 | 16140434 | 2,006 | Uneven distribution of MHC class II epitopes within the influenza virus. | Vaccine | Sherry R Crowe; Shannon C Miller; Deborah M Brown; Pamela S Adams; Richard W Dutton; Allen G Harmsen; Frances E Lund; Troy D Randall; Susan L Swain; David L Woodland | 64064 | M1 221-235 (x31) | FragmentOfANaturalSequenceMolecule | Peptide from protein | THPSSSAGLKNDLLE | 15 | null | 221 | 235 | 132504 | Q9IQ48.1 | null | Epitope containing region/antigenic site | Not determined | TCell | 1036087 | 48 | Figure 1 | Negative | false | null | 10000067 | F | 6-12 weeks | null | null | 167 168 | lymphocyte | spleen | Direct Ex Vivo | Exact match to reference information | Not determined | null | 5 |
1000157.xml | 1000157 | 2025-11-06-08:00 | 16140434 | 2,006 | Uneven distribution of MHC class II epitopes within the influenza virus. | Vaccine | Sherry R Crowe; Shannon C Miller; Deborah M Brown; Pamela S Adams; Richard W Dutton; Allen G Harmsen; Frances E Lund; Troy D Randall; Susan L Swain; David L Woodland | 43486 | M1 231-245 (x31) | FragmentOfANaturalSequenceMolecule | Peptide from protein | NDLLENLQAYQKRMG | 15 | null | 231 | 245 | 132504 | Q9IQ48.1 | null | Epitope containing region/antigenic site | Not determined | TCell | 1036089 | 48 | Figure 1 | Negative | false | null | 10000067 | F | 6-12 weeks | null | null | 167 168 | lymphocyte | spleen | Direct Ex Vivo | Exact match to reference information | Not determined | null | 5 |
1000157.xml | 1000157 | 2025-11-06-08:00 | 16140434 | 2,006 | Uneven distribution of MHC class II epitopes within the influenza virus. | Vaccine | Sherry R Crowe; Shannon C Miller; Deborah M Brown; Pamela S Adams; Richard W Dutton; Allen G Harmsen; Frances E Lund; Troy D Randall; Susan L Swain; David L Woodland | 51249 | M1 241-252 (x31) | FragmentOfANaturalSequenceMolecule | Peptide from protein | QKRMGVQMQRFK | 12 | null | 241 | 252 | 132504 | Q9IQ48.1 | null | Epitope containing region/antigenic site | Not determined | TCell | 1036091 | 48 | Figure 1 | Negative | false | null | 10000067 | F | 6-12 weeks | null | null | 167 168 | lymphocyte | spleen | Direct Ex Vivo | Exact match to reference information | Not determined | null | 3 |
1000157.xml | 1000157 | 2025-11-06-08:00 | 16140434 | 2,006 | Uneven distribution of MHC class II epitopes within the influenza virus. | Vaccine | Sherry R Crowe; Shannon C Miller; Deborah M Brown; Pamela S Adams; Richard W Dutton; Allen G Harmsen; Frances E Lund; Troy D Randall; Susan L Swain; David L Woodland | 42555 | M2 1-15 (x31) | FragmentOfANaturalSequenceMolecule | Peptide from protein | MSFLTEVETPIRNEW | 15 | null | 1 | 15 | 132504 | BAA99398.1 | null | Epitope containing region/antigenic site | Not determined | TCell | 1036092 | 48 | Figure 1 | Negative | false | null | 10000067 | F | 6-12 weeks | null | null | 167 168 | lymphocyte | spleen | Direct Ex Vivo | Exact match to reference information | Not determined | null | 1 |
1000157.xml | 1000157 | 2025-11-06-08:00 | 16140434 | 2,006 | Uneven distribution of MHC class II epitopes within the influenza virus. | Vaccine | Sherry R Crowe; Shannon C Miller; Deborah M Brown; Pamela S Adams; Richard W Dutton; Allen G Harmsen; Frances E Lund; Troy D Randall; Susan L Swain; David L Woodland | 14687 | M2 6-20 (x31) | FragmentOfANaturalSequenceMolecule | Peptide from protein | EVETPIRNEWGCRCN | 15 | null | 6 | 20 | 132504 | BAA99398.1 | null | Epitope containing region/antigenic site | Not determined | TCell | 1036093 | 48 | Figure 1 | Negative | false | null | 10000067 | F | 6-12 weeks | null | null | 167 168 | lymphocyte | spleen | Direct Ex Vivo | Exact match to reference information | Not determined | null | 9 |
1000157.xml | 1000157 | 2025-11-06-08:00 | 16140434 | 2,006 | Uneven distribution of MHC class II epitopes within the influenza virus. | Vaccine | Sherry R Crowe; Shannon C Miller; Deborah M Brown; Pamela S Adams; Richard W Dutton; Allen G Harmsen; Frances E Lund; Troy D Randall; Susan L Swain; David L Woodland | 28345 | M2 11-25 (x31) | FragmentOfANaturalSequenceMolecule | Peptide from protein | IRNEWGCRCNGSSDP | 15 | null | 11 | 25 | 132504 | BAA99398.1 | null | Epitope containing region/antigenic site | Not determined | TCell | 1036094 | 48 | Figure 1 | Negative | false | null | 10000067 | F | 6-12 weeks | null | null | 167 168 | lymphocyte | spleen | Direct Ex Vivo | Exact match to reference information | Not determined | null | 7 |
1000157.xml | 1000157 | 2025-11-06-08:00 | 16140434 | 2,006 | Uneven distribution of MHC class II epitopes within the influenza virus. | Vaccine | Sherry R Crowe; Shannon C Miller; Deborah M Brown; Pamela S Adams; Richard W Dutton; Allen G Harmsen; Frances E Lund; Troy D Randall; Susan L Swain; David L Woodland | 18902 | M2 16-30 (x31) | FragmentOfANaturalSequenceMolecule | Peptide from protein | GCRCNGSSDPLTIAA | 15 | null | 16 | 30 | 132504 | BAA99398.1 | null | Epitope containing region/antigenic site | Not determined | TCell | 1036095 | 48 | Figure 1 | Negative | false | null | 10000067 | F | 6-12 weeks | null | null | 167 168 | lymphocyte | spleen | Direct Ex Vivo | Exact match to reference information | Not determined | null | 2 |
1000157.xml | 1000157 | 2025-11-06-08:00 | 16140434 | 2,006 | Uneven distribution of MHC class II epitopes within the influenza virus. | Vaccine | Sherry R Crowe; Shannon C Miller; Deborah M Brown; Pamela S Adams; Richard W Dutton; Allen G Harmsen; Frances E Lund; Troy D Randall; Susan L Swain; David L Woodland | 22498 | M2 21-35 (x31) | FragmentOfANaturalSequenceMolecule | Peptide from protein | GSSDPLTIAANIIGI | 15 | null | 21 | 35 | 132504 | BAA99398.1 | null | Epitope containing region/antigenic site | Not determined | TCell | 1036096 | 48 | Figure 1 | Negative | false | null | 10000067 | F | 6-12 weeks | null | null | 167 168 | lymphocyte | spleen | Direct Ex Vivo | Exact match to reference information | Not determined | null | 9 |
1000157.xml | 1000157 | 2025-11-06-08:00 | 16140434 | 2,006 | Uneven distribution of MHC class II epitopes within the influenza virus. | Vaccine | Sherry R Crowe; Shannon C Miller; Deborah M Brown; Pamela S Adams; Richard W Dutton; Allen G Harmsen; Frances E Lund; Troy D Randall; Susan L Swain; David L Woodland | 39949 | M2 26-40 (x31) | FragmentOfANaturalSequenceMolecule | Peptide from protein | LTIAANIIGILHLTL | 15 | null | 26 | 40 | 132504 | BAA99398.1 | null | Epitope containing region/antigenic site | Not determined | TCell | 1036097 | 48 | Figure 1 | Negative | false | null | 10000067 | F | 6-12 weeks | null | null | 167 168 | lymphocyte | spleen | Direct Ex Vivo | Exact match to reference information | Not determined | null | 7 |
1000157.xml | 1000157 | 2025-11-06-08:00 | 16140434 | 2,006 | Uneven distribution of MHC class II epitopes within the influenza virus. | Vaccine | Sherry R Crowe; Shannon C Miller; Deborah M Brown; Pamela S Adams; Richard W Dutton; Allen G Harmsen; Frances E Lund; Troy D Randall; Susan L Swain; David L Woodland | 44243 | M2 31-45 (x31) | FragmentOfANaturalSequenceMolecule | Peptide from protein | NIIGILHLTLWMLDR | 15 | null | 31 | 45 | 132504 | BAA99398.1 | null | Epitope containing region/antigenic site | Not determined | TCell | 1036098 | 48 | Figure 1 | Negative | false | null | 10000067 | F | 6-12 weeks | null | null | 167 168 | lymphocyte | spleen | Direct Ex Vivo | Exact match to reference information | Not determined | null | 2 |
1000157.xml | 1000157 | 2025-11-06-08:00 | 16140434 | 2,006 | Uneven distribution of MHC class II epitopes within the influenza virus. | Vaccine | Sherry R Crowe; Shannon C Miller; Deborah M Brown; Pamela S Adams; Richard W Dutton; Allen G Harmsen; Frances E Lund; Troy D Randall; Susan L Swain; David L Woodland | 72852 | M2 41-55 (x31) | FragmentOfANaturalSequenceMolecule | Peptide from protein | WMLDRLFFKCIYRRF | 15 | null | 41 | 55 | 132504 | BAA99398.1 | null | Epitope containing region/antigenic site | Not determined | TCell | 1036100 | 48 | Figure 1 | Negative | false | null | 10000067 | F | 6-12 weeks | null | null | 167 168 | lymphocyte | spleen | Direct Ex Vivo | Exact match to reference information | Not determined | null | 4 |
1000157.xml | 1000157 | 2025-11-06-08:00 | 16140434 | 2,006 | Uneven distribution of MHC class II epitopes within the influenza virus. | Vaccine | Sherry R Crowe; Shannon C Miller; Deborah M Brown; Pamela S Adams; Richard W Dutton; Allen G Harmsen; Frances E Lund; Troy D Randall; Susan L Swain; David L Woodland | 35827 | M2 46-60 (x31) | FragmentOfANaturalSequenceMolecule | Peptide from protein | LFFKCIYRRFKYGLK | 15 | null | 46 | 60 | 132504 | BAA99398.1 | null | Epitope containing region/antigenic site | Not determined | TCell | 1036101 | 48 | Figure 1 | Negative | false | null | 10000067 | F | 6-12 weeks | null | null | 167 168 | lymphocyte | spleen | Direct Ex Vivo | Exact match to reference information | Not determined | null | 6 |
1000157.xml | 1000157 | 2025-11-06-08:00 | 16140434 | 2,006 | Uneven distribution of MHC class II epitopes within the influenza virus. | Vaccine | Sherry R Crowe; Shannon C Miller; Deborah M Brown; Pamela S Adams; Richard W Dutton; Allen G Harmsen; Frances E Lund; Troy D Randall; Susan L Swain; David L Woodland | 29671 | M2 51-65 (x31) | FragmentOfANaturalSequenceMolecule | Peptide from protein | IYRRFKYGLKGGPST | 15 | null | 51 | 65 | 132504 | BAA99398.1 | null | Epitope containing region/antigenic site | Not determined | TCell | 1036102 | 48 | Figure 1 | Negative | false | null | 10000067 | F | 6-12 weeks | null | null | 167 168 | lymphocyte | spleen | Direct Ex Vivo | Exact match to reference information | Not determined | null | 6 |
1000157.xml | 1000157 | 2025-11-06-08:00 | 16140434 | 2,006 | Uneven distribution of MHC class II epitopes within the influenza virus. | Vaccine | Sherry R Crowe; Shannon C Miller; Deborah M Brown; Pamela S Adams; Richard W Dutton; Allen G Harmsen; Frances E Lund; Troy D Randall; Susan L Swain; David L Woodland | 19973 | M2 61-75 (x31) | FragmentOfANaturalSequenceMolecule | Peptide from protein | GGPSTEGVPKSMREE | 15 | null | 61 | 75 | 132504 | BAA99398.1 | null | Epitope containing region/antigenic site | Not determined | TCell | 1036104 | 48 | Figure 1 | Negative | false | null | 10000067 | F | 6-12 weeks | null | null | 167 168 | lymphocyte | spleen | Direct Ex Vivo | Exact match to reference information | Not determined | null | 6 |
1000157.xml | 1000157 | 2025-11-06-08:00 | 16140434 | 2,006 | Uneven distribution of MHC class II epitopes within the influenza virus. | Vaccine | Sherry R Crowe; Shannon C Miller; Deborah M Brown; Pamela S Adams; Richard W Dutton; Allen G Harmsen; Frances E Lund; Troy D Randall; Susan L Swain; David L Woodland | 12305 | M2 66-80 (x31) | FragmentOfANaturalSequenceMolecule | Peptide from protein | EGVPKSMREEYRKEQ | 15 | null | 66 | 80 | 132504 | BAA99398.1 | null | Epitope containing region/antigenic site | Not determined | TCell | 1036105 | 48 | Figure 1 | Negative | false | null | 10000067 | F | 6-12 weeks | null | null | 167 168 | lymphocyte | spleen | Direct Ex Vivo | Exact match to reference information | Not determined | null | 3 |
1000157.xml | 1000157 | 2025-11-06-08:00 | 16140434 | 2,006 | Uneven distribution of MHC class II epitopes within the influenza virus. | Vaccine | Sherry R Crowe; Shannon C Miller; Deborah M Brown; Pamela S Adams; Richard W Dutton; Allen G Harmsen; Frances E Lund; Troy D Randall; Susan L Swain; David L Woodland | 59743 | M2 71-85 (x31) | FragmentOfANaturalSequenceMolecule | Peptide from protein | SMREEYRKEQQSAVD | 15 | null | 71 | 85 | 132504 | BAA99398.1 | null | Epitope containing region/antigenic site | Not determined | TCell | 1036106 | 48 | Figure 1 | Negative | false | null | 10000067 | F | 6-12 weeks | null | null | 167 168 | lymphocyte | spleen | Direct Ex Vivo | Exact match to reference information | Not determined | null | 7 |
1000157.xml | 1000157 | 2025-11-06-08:00 | 16140434 | 2,006 | Uneven distribution of MHC class II epitopes within the influenza virus. | Vaccine | Sherry R Crowe; Shannon C Miller; Deborah M Brown; Pamela S Adams; Richard W Dutton; Allen G Harmsen; Frances E Lund; Troy D Randall; Susan L Swain; David L Woodland | 75624 | M2 76-90 (x31) | FragmentOfANaturalSequenceMolecule | Peptide from protein | YRKEQQSAVDTDDGH | 15 | null | 76 | 90 | 132504 | BAA99398.1 | null | Epitope containing region/antigenic site | Not determined | TCell | 1036107 | 48 | Figure 1 | Negative | false | null | 10000067 | F | 6-12 weeks | null | null | 167 168 | lymphocyte | spleen | Direct Ex Vivo | Exact match to reference information | Not determined | null | 6 |
1000157.xml | 1000157 | 2025-11-06-08:00 | 16140434 | 2,006 | Uneven distribution of MHC class II epitopes within the influenza virus. | Vaccine | Sherry R Crowe; Shannon C Miller; Deborah M Brown; Pamela S Adams; Richard W Dutton; Allen G Harmsen; Frances E Lund; Troy D Randall; Susan L Swain; David L Woodland | 52296 | M2 81-95 (x31) | FragmentOfANaturalSequenceMolecule | Peptide from protein | QSAVDTDDGHFVSIE | 15 | null | 81 | 95 | 132504 | BAA99398.1 | null | Epitope containing region/antigenic site | Not determined | TCell | 1036108 | 48 | Figure 1 | Negative | false | null | 10000067 | F | 6-12 weeks | null | null | 167 168 | lymphocyte | spleen | Direct Ex Vivo | Exact match to reference information | Not determined | null | 6 |
1000157.xml | 1000157 | 2025-11-06-08:00 | 16140434 | 2,006 | Uneven distribution of MHC class II epitopes within the influenza virus. | Vaccine | Sherry R Crowe; Shannon C Miller; Deborah M Brown; Pamela S Adams; Richard W Dutton; Allen G Harmsen; Frances E Lund; Troy D Randall; Susan L Swain; David L Woodland | 63129 | M2 86-97 (x31) | FragmentOfANaturalSequenceMolecule | Peptide from protein | TDDGHFVSIELE | 12 | null | 86 | 97 | 132504 | BAA99398.1 | null | Epitope containing region/antigenic site | Not determined | TCell | 1036109 | 48 | Figure 1 | Negative | false | null | 10000067 | F | 6-12 weeks | null | null | 167 168 | lymphocyte | spleen | Direct Ex Vivo | Exact match to reference information | Not determined | null | 4 |
1000158.xml | 1000158 | 2025-11-06-08:00 | 16054612 | 2,005 | Strong memory CD8+ T cell responses against immunodominant and three new subdominant HLA-B27-restricted influenza A CTL epitopes following secondary infection of HLA-B27 transgenic mice. | Cellular immunology | Eve Cheuk; John W Chamberlain | 4602 | NP 366-374 | FragmentOfANaturalSequenceMolecule | Peptide from protein | ASNENMETM | 9 | null | 366 | 374 | 132504 | Q91UL1.1 | null | Exact Epitope | Representative selection | TCell | 1004177 | 48 | Figure 3 | Positive | true | 40000.0 | 10000067 | null | null | null | 172 | null | splenocyte | spleen | Direct Ex Vivo | Exact match to reference information | Not determined | null | 9 |
1000158.xml | 1000158 | 2025-11-06-08:00 | 16054612 | 2,005 | Strong memory CD8+ T cell responses against immunodominant and three new subdominant HLA-B27-restricted influenza A CTL epitopes following secondary infection of HLA-B27 transgenic mice. | Cellular immunology | Eve Cheuk; John W Chamberlain | 60867 | NP 383-391 | FragmentOfANaturalSequenceMolecule | Peptide from protein | SRYWAIRTR | 9 | null | 383 | 391 | 132504 | Q91UL1.1 | null | Exact Epitope | Representative selection | TCell | 1004178 | 48 | Figure 3 | Positive | true | 20000.0 | 10000594 | null | null | null | 190 | null | splenocyte | spleen | Direct Ex Vivo | Exact match to reference information | Not determined | null | 7 |
1000158.xml | 1000158 | 2025-11-06-08:00 | 16054612 | 2,005 | Strong memory CD8+ T cell responses against immunodominant and three new subdominant HLA-B27-restricted influenza A CTL epitopes following secondary infection of HLA-B27 transgenic mice. | Cellular immunology | Eve Cheuk; John W Chamberlain | 55766 | NP 98-106 | FragmentOfANaturalSequenceMolecule | Peptide from protein | RRVNGKWMR | 9 | null | 98 | 106 | 132504 | Q91UL1.1 | null | Exact Epitope | Representative selection | TCell | 1004186 | 48 | Figure 5 | Negative | false | null | 10000594 | null | null | null | 190 | null | splenocyte | spleen | Direct Ex Vivo | Exact match to reference information | Not determined | null | 3 |
1000158.xml | 1000158 | 2025-11-06-08:00 | 16054612 | 2,005 | Strong memory CD8+ T cell responses against immunodominant and three new subdominant HLA-B27-restricted influenza A CTL epitopes following secondary infection of HLA-B27 transgenic mice. | Cellular immunology | Eve Cheuk; John W Chamberlain | 22242 | HA 216-224 | FragmentOfANaturalSequenceMolecule | Peptide from protein | GRVTVSTRR | 9 | null | 216 | 224 | 132504 | P03437.1 | null | Exact Epitope | Representative selection | TCell | 1004197 | 48 | Figure 5 | Negative | false | null | 10000594 | null | null | null | 190 | null | splenocyte | spleen | Direct Ex Vivo | Exact match to reference information | Not determined | null | 7 |
1000158.xml | 1000158 | 2025-11-06-08:00 | 16054612 | 2,005 | Strong memory CD8+ T cell responses against immunodominant and three new subdominant HLA-B27-restricted influenza A CTL epitopes following secondary infection of HLA-B27 transgenic mice. | Cellular immunology | Eve Cheuk; John W Chamberlain | 33195 | M1 242-250 | FragmentOfANaturalSequenceMolecule | Peptide from protein | KRMGVQMQR | 9 | null | 242 | 250 | 132504 | Q9IQ48.1 | null | Exact Epitope | Representative selection | TCell | 1004198 | 48 | Figure 5 | Negative | false | null | 10000594 | null | null | null | 190 | null | splenocyte | spleen | Direct Ex Vivo | Exact match to reference information | Not determined | null | 1 |
1000158.xml | 1000158 | 2025-11-06-08:00 | 16054612 | 2,005 | Strong memory CD8+ T cell responses against immunodominant and three new subdominant HLA-B27-restricted influenza A CTL epitopes following secondary infection of HLA-B27 transgenic mice. | Cellular immunology | Eve Cheuk; John W Chamberlain | 55531 | PB2 368-376 | FragmentOfANaturalSequenceMolecule | Peptide from protein | RRATAILRK | 9 | null | 368 | 376 | 132504 | Q9IQ45.1 | null | Exact Epitope | Not determined | TCell | 1004200 | 48 | Figure 5 | Positive | true | null | 10000594 | null | null | null | 190 | null | splenocyte | spleen | Direct Ex Vivo | Exact match to reference information | Not determined | null | 1 |
1000158.xml | 1000158 | 2025-11-06-08:00 | 16054612 | 2,005 | Strong memory CD8+ T cell responses against immunodominant and three new subdominant HLA-B27-restricted influenza A CTL epitopes following secondary infection of HLA-B27 transgenic mice. | Cellular immunology | Eve Cheuk; John W Chamberlain | 33257 | PB2 702-710 | FragmentOfANaturalSequenceMolecule | Peptide from protein | KRYGPALSI | 9 | null | 702 | 710 | 132504 | Q9IQ45.1 | null | Exact Epitope | Not determined | TCell | 1004201 | 48 | Figure 5 | Positive | true | null | 10000594 | null | null | null | 190 | null | splenocyte | spleen | Direct Ex Vivo | Exact match to reference information | Not determined | null | 1 |
1000158.xml | 1000158 | 2025-11-06-08:00 | 16054612 | 2,005 | Strong memory CD8+ T cell responses against immunodominant and three new subdominant HLA-B27-restricted influenza A CTL epitopes following secondary infection of HLA-B27 transgenic mice. | Cellular immunology | Eve Cheuk; John W Chamberlain | 60850 | NS1 87-95 | FragmentOfANaturalSequenceMolecule | Peptide from protein | SRYLTDMTL | 9 | null | 87 | 95 | 132504 | Q76MT8.1 | null | Exact Epitope | Not determined | TCell | 1004202 | 48 | Figure 5 | Negative | false | null | 10000594 | null | null | null | 190 | null | splenocyte | spleen | Direct Ex Vivo | Exact match to reference information | Not determined | null | 8 |
1000159.xml | 1000159 | 2025-11-06-08:00 | 10229842 | 1,999 | Covalent linkage to beta2-microglobulin enhances the MHC stability and antigenicity of suboptimal CTL epitopes. | Journal of immunology (Baltimore, Md. : 1950) | R A Uger; S M Chan; B H Barber | 4602 | NP 366-374 | FragmentOfANaturalSequenceMolecule | Peptide from protein | ASNENMETM | 9 | null | 366 | 374 | 11320 | null | null | Exact Epitope | Representative selection | TCell | 1004022 | 67 | Figure 4A | Positive | true | null | 10000067 | null | null | null | 172 | null | splenocyte | spleen | Short Term Restimulated | Exact match to reference information | Representative selection | null | 9 |
1000159.xml | 1000159 | 2025-11-06-08:00 | 10229842 | 1,999 | Covalent linkage to beta2-microglobulin enhances the MHC stability and antigenicity of suboptimal CTL epitopes. | Journal of immunology (Baltimore, Md. : 1950) | R A Uger; S M Chan; B H Barber | 4602 | NP 366-374 | FragmentOfANaturalSequenceMolecule | Peptide from protein | ASNENMETM | 9 | null | 366 | 374 | 11320 | null | null | Exact Epitope | Representative selection | MhcBinding | 1003893 | 185 | Figure 3a | Positive | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 9 |
1000159.xml | 1000159 | 2025-11-06-08:00 | 10229842 | 1,999 | Covalent linkage to beta2-microglobulin enhances the MHC stability and antigenicity of suboptimal CTL epitopes. | Journal of immunology (Baltimore, Md. : 1950) | R A Uger; S M Chan; B H Barber | 4200 | R2 | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ARNENMETM | 9 | null | null | null | null | null | null | Exact Epitope | null | TCell | 1004025 | 67 | Figure 4A | Positive | true | null | 10000067 | null | null | null | 172 | null | splenocyte | spleen | Short Term Restimulated | Exact match to reference information | Representative selection | null | 6 |
1000159.xml | 1000159 | 2025-11-06-08:00 | 10229842 | 1,999 | Covalent linkage to beta2-microglobulin enhances the MHC stability and antigenicity of suboptimal CTL epitopes. | Journal of immunology (Baltimore, Md. : 1950) | R A Uger; S M Chan; B H Barber | 4200 | R2 | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ARNENMETM | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 1004023 | 185 | Figure 3b | Positive | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 6 |
1000159.xml | 1000159 | 2025-11-06-08:00 | 10229842 | 1,999 | Covalent linkage to beta2-microglobulin enhances the MHC stability and antigenicity of suboptimal CTL epitopes. | Journal of immunology (Baltimore, Md. : 1950) | R A Uger; S M Chan; B H Barber | 733 | D2 | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ADNENMETM | 9 | null | null | null | null | null | null | Exact Epitope | null | TCell | 1004030 | 67 | Figure 4A | Positive | true | null | 10000067 | null | null | null | 172 | null | splenocyte | spleen | Short Term Restimulated | Exact match to reference information | Representative selection | null | 5 |
1000159.xml | 1000159 | 2025-11-06-08:00 | 10229842 | 1,999 | Covalent linkage to beta2-microglobulin enhances the MHC stability and antigenicity of suboptimal CTL epitopes. | Journal of immunology (Baltimore, Md. : 1950) | R A Uger; S M Chan; B H Barber | 733 | D2 | SequenceMoleculeNoNaturalSource | Peptide, no natural source | ADNENMETM | 9 | null | null | null | null | null | null | Exact Epitope | null | MhcBinding | 1004028 | 185 | Figure 3b | Positive | true | null | null | null | null | null | null | null | null | null | null | null | null | null | 5 |
1000159.xml | 1000159 | 2025-11-06-08:00 | 10229842 | 1,999 | Covalent linkage to beta2-microglobulin enhances the MHC stability and antigenicity of suboptimal CTL epitopes. | Journal of immunology (Baltimore, Md. : 1950) | R A Uger; S M Chan; B H Barber | 67436 | NP 147-155 | FragmentOfANaturalSequenceMolecule | Peptide from protein | TYQRTRALV | 9 | null | 147 | 155 | 11320 | null | null | Exact Epitope | Representative selection | TCell | 1004034 | 67 | Figure 1A, Figure 1B | Positive | true | null | 10000000 | null | null | null | 172 | null | splenocyte | spleen | Short Term Restimulated | Exact match to reference information | Representative selection | null | 9 |
1000161.xml | 1000161 | 2025-11-06-08:00 | 10930688 | 2,000 | Recombinant modified vaccinia virus Ankara efficiently restimulates human cytotoxic T lymphocytes in vitro. | Vaccine | L Dorrell; C A O'Callaghan; W Britton; S Hambleton; A McMichael; G L Smith; S Rowland-Jones; T J Blanchard | 13263 | NP 380-388 | FragmentOfANaturalSequenceMolecule | Peptide from protein | ELRSRYWAI | 9 | null | 380 | 388 | 11320 | null | null | Exact Epitope | Not determined | TCell | 1003898 | 67 | Figure 1a, 1c, 2a, and Table 1 | Positive | true | null | 9606 | null | null | null | 301 | null | PBMC | blood | Short Term Restimulated | Exact match to reference information | Not determined | null | 8 |
1000161.xml | 1000161 | 2025-11-06-08:00 | 10930688 | 2,000 | Recombinant modified vaccinia virus Ankara efficiently restimulates human cytotoxic T lymphocytes in vitro. | Vaccine | L Dorrell; C A O'Callaghan; W Britton; S Hambleton; A McMichael; G L Smith; S Rowland-Jones; T J Blanchard | 13263 | NP 380-388 | FragmentOfANaturalSequenceMolecule | Peptide from protein | ELRSRYWAI | 9 | null | 380 | 388 | 11320 | null | null | Exact Epitope | Not determined | TCell | 1004884 | 47 | Figure 5 | Positive | true | 5.1 | 9606 | null | null | null | 301 | null | PBMC | blood | Short Term Restimulated | Exact match to reference information | Not determined | null | 8 |
1000161.xml | 1000161 | 2025-11-06-08:00 | 10930688 | 2,000 | Recombinant modified vaccinia virus Ankara efficiently restimulates human cytotoxic T lymphocytes in vitro. | Vaccine | L Dorrell; C A O'Callaghan; W Britton; S Hambleton; A McMichael; G L Smith; S Rowland-Jones; T J Blanchard | 13263 | NP 380-388 | FragmentOfANaturalSequenceMolecule | Peptide from protein | ELRSRYWAI | 9 | null | 380 | 388 | 11320 | null | null | Exact Epitope | Not determined | TCell | 1003901 | 67 | Figure 1b,1d, 2a and Table 1 | Positive | true | null | 9606 | null | null | null | 301 | null | PBMC | blood | Short Term Restimulated | Exact match to reference information | Not determined | null | 8 |
1000161.xml | 1000161 | 2025-11-06-08:00 | 10930688 | 2,000 | Recombinant modified vaccinia virus Ankara efficiently restimulates human cytotoxic T lymphocytes in vitro. | Vaccine | L Dorrell; C A O'Callaghan; W Britton; S Hambleton; A McMichael; G L Smith; S Rowland-Jones; T J Blanchard | 13263 | NP 380-388 | FragmentOfANaturalSequenceMolecule | Peptide from protein | ELRSRYWAI | 9 | null | 380 | 388 | 11320 | null | null | Exact Epitope | Not determined | TCell | 1003917 | 67 | Table 1 | Positive | true | null | 9606 | null | null | null | 301 | null | PBMC | blood | Short Term Restimulated | Exact match to reference information | Not determined | null | 8 |
1000161.xml | 1000161 | 2025-11-06-08:00 | 10930688 | 2,000 | Recombinant modified vaccinia virus Ankara efficiently restimulates human cytotoxic T lymphocytes in vitro. | Vaccine | L Dorrell; C A O'Callaghan; W Britton; S Hambleton; A McMichael; G L Smith; S Rowland-Jones; T J Blanchard | 27283 | NP 265-273 | FragmentOfANaturalSequenceMolecule | Peptide from protein | ILRGSVAHK | 9 | null | 265 | 273 | 11320 | null | null | Exact Epitope | Not determined | TCell | 1003902 | 67 | Figure 1e and Table 1 | Positive | true | null | 9606 | null | null | null | 242 | null | PBMC | blood | Short Term Restimulated | Exact match to reference information | Not determined | null | 5 |
1000161.xml | 1000161 | 2025-11-06-08:00 | 10930688 | 2,000 | Recombinant modified vaccinia virus Ankara efficiently restimulates human cytotoxic T lymphocytes in vitro. | Vaccine | L Dorrell; C A O'Callaghan; W Britton; S Hambleton; A McMichael; G L Smith; S Rowland-Jones; T J Blanchard | 27283 | NP 265-273 | FragmentOfANaturalSequenceMolecule | Peptide from protein | ILRGSVAHK | 9 | null | 265 | 273 | 11320 | null | null | Exact Epitope | Not determined | TCell | 1003903 | 67 | Figure 1f and Table 1 | Positive | true | null | 9606 | null | null | null | 242 | null | PBMC | blood | Short Term Restimulated | Exact match to reference information | Not determined | null | 5 |
1000161.xml | 1000161 | 2025-11-06-08:00 | 10930688 | 2,000 | Recombinant modified vaccinia virus Ankara efficiently restimulates human cytotoxic T lymphocytes in vitro. | Vaccine | L Dorrell; C A O'Callaghan; W Britton; S Hambleton; A McMichael; G L Smith; S Rowland-Jones; T J Blanchard | 60867 | NP 383-391 | FragmentOfANaturalSequenceMolecule | Peptide from protein | SRYWAIRTR | 9 | null | 383 | 391 | 11320 | null | null | Exact Epitope | Not determined | TCell | 1003909 | 67 | Figure 2b | Positive | true | null | 9606 | null | null | null | 190 | null | PBMC | blood | Short Term Restimulated | Exact match to reference information | Not determined | null | 7 |
1000161.xml | 1000161 | 2025-11-06-08:00 | 10930688 | 2,000 | Recombinant modified vaccinia virus Ankara efficiently restimulates human cytotoxic T lymphocytes in vitro. | Vaccine | L Dorrell; C A O'Callaghan; W Britton; S Hambleton; A McMichael; G L Smith; S Rowland-Jones; T J Blanchard | 60867 | NP 383-391 | FragmentOfANaturalSequenceMolecule | Peptide from protein | SRYWAIRTR | 9 | null | 383 | 391 | 11320 | null | null | Exact Epitope | Not determined | TCell | 1003910 | 67 | Figure 2b | Positive | true | null | 9606 | null | null | null | 190 | null | PBMC | blood | Short Term Restimulated | Exact match to reference information | Not determined | null | 7 |
1000161.xml | 1000161 | 2025-11-06-08:00 | 10930688 | 2,000 | Recombinant modified vaccinia virus Ankara efficiently restimulates human cytotoxic T lymphocytes in vitro. | Vaccine | L Dorrell; C A O'Callaghan; W Britton; S Hambleton; A McMichael; G L Smith; S Rowland-Jones; T J Blanchard | 65702 | gag 180-188 | FragmentOfANaturalSequenceMolecule | Peptide from protein | TPQDLNMML | 9 | null | 180 | 188 | 11676 | AAV85042.1 | null | Exact Epitope | Not determined | TCell | 1003919 | 67 | Figure 6 | Positive | true | null | 9606 | null | null | null | 292 | null | PBMC | blood | Short Term Restimulated | Exact match to reference information | Not determined | null | 6 |
1000161.xml | 1000161 | 2025-11-06-08:00 | 10930688 | 2,000 | Recombinant modified vaccinia virus Ankara efficiently restimulates human cytotoxic T lymphocytes in vitro. | Vaccine | L Dorrell; C A O'Callaghan; W Britton; S Hambleton; A McMichael; G L Smith; S Rowland-Jones; T J Blanchard | 65702 | gag 180-188 | FragmentOfANaturalSequenceMolecule | Peptide from protein | TPQDLNMML | 9 | null | 180 | 188 | 11676 | AAV85042.1 | null | Exact Epitope | Not determined | TCell | 1003924 | 67 | Figure 6 | Positive | true | null | 9606 | null | null | null | 292 | null | PBMC | blood | Short Term Restimulated | Exact match to reference information | Not determined | null | 6 |
1000161.xml | 1000161 | 2025-11-06-08:00 | 10930688 | 2,000 | Recombinant modified vaccinia virus Ankara efficiently restimulates human cytotoxic T lymphocytes in vitro. | Vaccine | L Dorrell; C A O'Callaghan; W Britton; S Hambleton; A McMichael; G L Smith; S Rowland-Jones; T J Blanchard | 76251 | gag 298-306 | FragmentOfANaturalSequenceMolecule | Peptide from protein | YVDRFFKTL | 9 | null | 293 | 301 | 11676 | AAW03034.1 | null | Exact Epitope | Not determined | TCell | 1003925 | 67 | Figure 6 | Positive | true | null | 9606 | null | null | null | 239 | null | PBMC | blood | Short Term Restimulated | Exact match to reference information | Not determined | null | 3 |
1000161.xml | 1000161 | 2025-11-06-08:00 | 10930688 | 2,000 | Recombinant modified vaccinia virus Ankara efficiently restimulates human cytotoxic T lymphocytes in vitro. | Vaccine | L Dorrell; C A O'Callaghan; W Britton; S Hambleton; A McMichael; G L Smith; S Rowland-Jones; T J Blanchard | 76251 | gag 298-306 | FragmentOfANaturalSequenceMolecule | Peptide from protein | YVDRFFKTL | 9 | null | 293 | 301 | 11676 | AAW03034.1 | null | Exact Epitope | Not determined | TCell | 1003926 | 67 | Figure 6 | Positive | true | null | 9606 | null | null | null | 239 | null | PBMC | blood | Short Term Restimulated | Exact match to reference information | Not determined | null | 3 |
1000163.xml | 1000163 | 2025-11-06-08:00 | 9314554 | 1,997 | Initiation codon scanthrough versus termination codon readthrough demonstrates strong potential for major histocompatibility complex class I-restricted cryptic epitope expression. | The Journal of experimental medicine | T N Bullock; A E Patterson; L L Franlin; E Notidis; L C Eisenlohr | 57322 | NP 50-57 | FragmentOfANaturalSequenceMolecule | Peptide from protein | SDYEGRLI | 8 | null | 50 | 57 | 11320 | P18072.1 | null | Exact Epitope | Not determined | TCell | 1005954 | 67 | Figures 1, 2, 3 and 4 | Positive | true | null | 10000228 | F | 6-8 weeks | null | 125 | null | T cell CD8+ | spleen | Short Term Restimulated | Not determined | Exact match to reference information | null | 4 |
1000163.xml | 1000163 | 2025-11-06-08:00 | 9314554 | 1,997 | Initiation codon scanthrough versus termination codon readthrough demonstrates strong potential for major histocompatibility complex class I-restricted cryptic epitope expression. | The Journal of experimental medicine | T N Bullock; A E Patterson; L L Franlin; E Notidis; L C Eisenlohr | 67436 | NP 147-155 | FragmentOfANaturalSequenceMolecule | Peptide from protein | TYQRTRALV | 9 | null | 147 | 155 | 11320 | P18072.1 | null | Exact Epitope | Not determined | TCell | 1005955 | 67 | Figures 1 and 3 | Positive | true | null | 10000000 | F | 6-8 weeks | null | 124 | null | T cell CD8+ | spleen | Short Term Restimulated | Not determined | Exact match to reference information | null | 9 |
1000164.xml | 1000164 | 2025-11-06-08:00 | 9705959 | 1,998 | Glycan-regulated antigen processing of a protein in the endoplasmic reticulum can uncover cryptic cytotoxic T cell epitopes. | The Journal of experimental medicine | P Wood; T Elliott | 4578 | NP 366-374 | FragmentOfANaturalSequenceMolecule | Peptide from protein | ASNENMDAM | 9 | null | 366 | 374 | 384505 | P03467.1 | null | Exact Epitope | Not determined | TCell | 1004057 | 67 | Figures 1A, 1C, 2 and 3 | Positive | true | null | 10000067 | null | null | null | 172 | null | T cell | null | Cell Line / Clone | Representative selection | Exact match to reference information | null | 4 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.